CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.
Abstract
CBS domains are defined as sequence motifs that occur in several different proteins in all kingdoms of life. Although thought to be regulatory, their exact functions have been unknown. However, their importance was underlined by findings that mutations in conserved residues within them cause a variety of human hereditary diseases, including (with the gene mutated in parentheses): Wolff-Parkinson-White syndrome (gamma 2 subunit of AMP-activated protein kinase); retinitis pigmentosa (IMP dehydrogenase-1); congenital myotonia, idiopathic generalized epilepsy, hypercalciuric nephrolithiasis, and classic Bartter syndrome (CLC chloride channel family members); and homocystinuria (cystathionine beta-synthase). AMP-activated protein kinase is a sensor of cellular energy status that is activated by AMP and inhibited by ATP, but the location of the regulatory nucleotide-binding sites (which are prime targets for drugs to treat obesity and diabetes) was not characterized. We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine beta-synthase bind AMP, ATP, or S-adenosyl methionine,while mutations that cause hereditary diseases impair this binding. This shows that tandem pairs of CBS domains act, in most cases, as sensors of cellular energy status and, as such, represent a newly identified class of binding domain for adenosine derivatives.
Overview
CoChat Summary
## TL;DR
This paper shows that tandem CBS domain pairs act as allosteric binding modules for adenosine-related ligands, including AMP and ATP in AMPK, ATP in IMPDH and CLC2, and SAM in cystathionine β-synthase. It also shows that disease-associated mutations in these domains weaken ligand binding and, in AMPK, impair AMP-dependent activation.
## Key findings
- For AMPKγ2, the isolated CBS1-2 pair bound 1 AMP molecule with Kd = 53 ± 5 µM, and the CBS3-4 pair bound 1 AMP molecule with Kd = 104 ± 10 µM; the full CBS1-4 construct bound 2 AMP molecules with B0.5 = 61 ± 2 µM and Hill coefficient = 2.2 ± 0.1.
- Disease mutations increased AMP binding constants for AMPKγ2 CBS constructs; for CBS1-4, B0.5 for AMP rose from 61 ± 2 µM (WT) to 158 ± 9 µM (R302Q), 725 ± 36 µM (H383R), 1,360 ± 47 µM (T400N), and 2,800 ± 220 µM (R531G).
- In recombinant α1β1γ2 AMPK heterotrimers, the A0.5 for AMP activation increased in the same order as binding defects: WT 7 ± 3 µM, L ins 9 ± 4 µM, R302Q 23 ± 6 µM, H383R 51 ± 40 µM, T400N 95 ± 32 µM, and R531G >100 µM; the paper also states the WT α1β1γ1, α1β1γ2, and α1β1γ3 complexes were stimulated 3.3-fold, 7.0-fold, and 1.5-fold by AMP, respectively.
- Other CBS-domain proteins showed the same pattern: IMPDH2 CBS domains bound 1 ATP molecule with Kd = 54 ± 6 µM, while the R224P mutation increased this to 450 ± 36 µM; full-length IMPDH2 bound ATP with B0.5 = 770 ± 50 µM and ATP stimulated IMPDH activity more than fourfold with A0.5 = 0.44 ± 0.05 mM and Hill coefficient = 1.3 ± 0.1; CLC2 CBS domains bound ATP with Kd = 1.06 ± 0.08 mM, and pathogenic mutations raised this to 10.4-fold (G715E) and 14-fold (G826D) higher; cystathionine β-synthase CBS domains bound SAM with Kd = 34 ± 2 µM, and D444N increased this 15-fold to 510 ± 70 µM.
## Methods
- The study cloned CBS-domain constructs from AMPKγ1, γ2, and γ3, IMPDH2, CLC2, and cystathionine β-synthase, expressed them mainly as GST fusions in bacteria, and introduced disease mutations by site-directed mutagenesis.
- Ligand binding was measured using radiolabeled AMP, ATP, or SAM with rapid filtration, and data were fit to single-site or Hill binding models; AMPK heterotrimers were also expressed in CCL13 cells and assayed for AMP-dependent activity after rapid or slow lysis.
- IMPDH2 enzymatic activity was measured by NADH formation at 340 nm in the presence or absence of ATP.
## Limitations
- The paper itself notes several unresolved issues: AMP activation of AMPK heterotrimers occurred at concentrations about tenfold lower than the B0.5 values for AMP binding to isolated CBS1-4 constructs; the three AMPKγ isoforms differed in AMP binding (20 µM, 53 µM, 125 µM) but the heterotrimers differed mainly in degree of stimulation rather than A0.5; and it states that further work is required to determine whether AMPK uses a mechanism similar to cAMP-dependent protein kinase.
- The text makes evident that some activation estimates are less precise because AMP could not be tested above 100 µM in heterotrimer assays, and the authors say the A0.5 values for H383R and T400N are less accurate, while no A0.5 could be obtained for R531G; this is an evidence-based limitation from the assay design.
- The study used purified domains and recombinant proteins in bacteria or cell culture, so direct in vivo physiology is not tested here; this is evident from the methods and experimental system, not explicitly stated as a limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 23 Not checked · 78 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| AMPK- γ 2 | CBS1-2 (WT) | 1 | 53 ± 5 | - | 175 ± 20 | - |”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant still bound AMP, but the K d increased 15-fold (Figure 1c and Table 1).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The K d for L ins was not significantly different from that for the WT.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 101 claims and to verify the 42 references still open.
- It may state two separate claims as one. 38
- The quote only partly states this claim. 1
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 4
“Binding of ATP by GST fusions of the isolated CBS domain pair (residues 112-232) ( a ) and full-length IMPDH2 (residues 1-514) ( b ).”
§ Methods
“The IMPDH2 constructs were polyhistidine-tagged and were purified on chelating Sepharose (Pharmacia, Chalfont St. Giles, United Kingdom) charged with 50 mM CoCl2 according to the manufacturer's instructions.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“the four tandem pairs of CBS domains in the γ subunits of AMPK provide two allosteric binding sites for AMP and ATP in the heterotrimeric complex”
§ Introduction
“the three γ subunit isoforms of AMPK, and their homologues in lower eukaryotes, are unique among eukaryotic proteins in having four tandem domains”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 3
“For the constructs from γ 1, γ 2, and γ 3, the B0.5 values for AMP were 20, 53, and 125 µ m, respectively.”
§ Methods
“| | CBS1-4 (WT) | 2 | 61 ± 2 | 2.2 ± 0.1 | 257 ± 14 | 2.2 ± 0.2 |”
Citations
Cites
1 retracted
Haug, K., Warnstedt, M., Alekov, A. K., Sander, T., Ramírez, A., Poser, B., Maljevic, S., Hebeisen, S., Kubisch, C., Rebstock, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1121 · Cited by 294
RetractedThe Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“It is also activated by the antidiabetic drugs metformin and rosiglitazone (21–23), and by the adipocyte-derived hormones leptin and adiponectin (24, 25).”
BackgroundCorton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Self-citationFryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
Self-citationNew drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
Self-citationWinder, W. W., & Hardie, D. G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e299 · Cited by 799 · cited 1×
“The kinase is activated by exercise in muscle (19), stimulating glucose and fatty acid oxidation (20), and may be partly responsible for the protective effects of exercise in the development of obesity and type 2 diabetes.”
BackgroundSelf-citationAMP‐activated protein kinase: the energy charge hypothesis revisited
Hardie, D. G., & Hawley, S. A. (2001) · BioEssays · doi:10.1002/bies.10009 · Cited by 784
Self-citationThe Pfam Protein Families Database
Bateman, A. G., Birney, E., Cerruti, L., Durbin, R. M., Etwiller, L., Eddy, S. R., Griffiths‐Jones, S., Howe, K., Marshall, M. S., & Sonnhammer, E. L. L. (2002) · PubMed Central · Cited by 764
A Mutation in PRKAG3 Associated with Excess Glycogen Content in Pig Skeletal Muscle
Milan, D., Jeon, J.-T., Looft, C., Amarger, V., Robic, A., Thelander, M., Rogel-Gaillard, C., Paul, S., Iannuccelli, N., Rask, L., et al. (2000) · Science · doi:10.1126/science.288.5469.1248 · Cited by 717
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Self-citationIdentification of a gene responsible for familial Wolff-Parkinson-White syndrome
Gollob, M. H., Green, M. S., Tang, A. S.-L., Gollob, T., Karibe, A., Hassan, A.-S., Ahmad, F., Lozado, R., Shah, G., Fananapazir, L., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106143442403 · Cited by 671
Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637
Self-citationThe regulation of AMP-activated protein kinase by phosphorylation
STEIN, S. C., Woods, A., Jones, N. A., DAVISON, M. D., & Carling, D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450437 · Cited by 605
The structure of a domain common to archaebacteria and the homocystinuria disease protein
Bateman, A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)30046-7 · Cited by 533
Blair, E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.11.1215 · Cited by 528
Arad, M., Benson, D. W., Perez-Atayde, A. R., McKenna, W. J., Sparks, E. A., Kanter, R. J., McGarry, K., Seidman, J. G., & Seidman, C. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214571 · Cited by 440
Sintchak, M. D., Fleming, M. A., Futer, O., Raybuck, S. A., Chambers, S. P., Caron, P. R., Murcko, M. A., & Wilson, K. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81275-1 · Cited by 423
Regulatory Subunit Of Protein Kinase A: Structure of Deletion Mutant with cAMP Binding Domains
Su, Y., Dostmann, W. R. G., Herberg, F. W., Durick, K., Xuong, N.-H., Ten Eyck, L., Taylor, S. S., & Varughese, K. I. (1995) · Science · doi:10.1126/science.7638597 · Cited by 393
Wilson, W. A., Hawley, S. A., & Hardie, D. G. (1996) · Current Biology · doi:10.1016/s0960-9822(96)00747-6 · Cited by 372
Self-citationHaug, K., Warnstedt, M., Alekov, A. K., Sander, T., Ramírez, A., Poser, B., Maljevic, S., Hebeisen, S., Kubisch, C., Rebstock, J., et al. (2009) · Nature Genetics · doi:10.1038/ng0909-1043 · Cited by 306
Iglesias, M. A., Ye, J.-M., Frangioudakis, G., Saha, A. K., Tomas, E., Ruderman, N. B., Cooney, G. J., & Kraegen, E. W. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2886 · Cited by 290
Mutations in the Chloride Channel Gene CLCNKB as a Cause of Classic Bartter Syndrome
KONRAD, M., VOLLMER, M., LEMMINK, H. H., VAN DEN HEUVEL, L. P. W. J., JECK, N., VARGAS-POUSSOU, R., LAKINGS, A., RUF, R., DESCHE[Combining Circumflex Accent]NES, G., ANTIGNAC, C., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181449 · Cited by 289
Bergeron, R., Previs, S. F., Cline, G. W., Perret, P., Russell III, R. R., Young, L. H., & Shulman, G. I. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1076 · Cited by 283
Gollob, M. H., Seger, J. J., Gollob, T. N., Tapscott, T., Gonzales, O., Bachinski, L., & Roberts, R. (2001) · Circulation · doi:10.1161/hc5001.102111 · Cited by 277
Woods, A., Salt, I., Scott, J., Hardie, D. G., & Carling, D. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01209-4 · Cited by 260
Self-citationCharacterization of AMP-activated Protein Kinase β and γ Subunits
Woods, A., Cheung, P. C. F., Smith, F. C., Davison, M. D., Scott, J., Beri, R. K., & Carling, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.10282 · Cited by 243
Self-citationBuhl, E. S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S. B., Pedersen, O., Schmitz, O., & Lund, S. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2199 · Cited by 240
Bowne, S. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.559 · Cited by 216
Myotonia caused by mutations in the muscle chloride channel geneCLCN1
Pusch, M. (2002) · Human Mutation · doi:10.1002/humu.10063 · Cited by 214
Song, X. M., Fiedler, M., Galuska, D., Ryder, J. W., Fernström, M., Chibalin, A. V., Wallberg-Henriksson, H., & Zierath, J. R. (2002) · Diabetologia · doi:10.1007/s125-002-8245-8 · Cited by 184
Characteristics and Crystal Structure of Bacterial Inosine-5‘-monophosphate Dehydrogenase,
Zhang, R.-G., Evans, G., Rotella, F. J., Westbrook, E. M., Beno, D., Huberman, E., Joachimiak, A., & Collart, F. R. (1999) · Biochemistry · doi:10.1021/bi982858v · Cited by 168
Kennan, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.547 · Cited by 167
Lloyd, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1233 · Cited by 158
Jánošík, M., Kéry, V., Gaustadnes, M., Maclean, K. N., & Kraus, J. P. (2001) · Biochemistry · doi:10.1021/bi010711p · Cited by 156
Kéry, V., Poneleit, L., & Kraus, J. P. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0723 · Cited by 136
Daniel, T., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207093200 · Cited by 119
Shan, X. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.6.635 · Cited by 110
An activating mutation in the γ1 subunit of the AMP‐activated protein kinase
Hamilton, S. R., Stapleton, D., O'Donnell, J. B., Kung, J. T., Dalal, S. R., Kemp, B. E., & Witters, L. A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02602-3 · Cited by 107
Kluijtmans, L. A., Boers, G. H., Stevens, E. M., Renier, W. O., Kraus, J. P., Trijbels, F. J., van den Heuvel, L. P., & Blom, H. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118791 · Cited by 95
Analysis of the Role of the AMP-Activated Protein Kinase in the Response to Cellular Stress
Hardie, D. G., Salt, I. P., & Davies, S. P. (2003) · Stress Response · doi:10.1385/1-59259-054-3:63 · Cited by 88
Self-citationAkeson, A. L., Woods, C. W., Hsieh, L. C., Bohnke, R. A., Ackermann, B. L., Chan, K. Y., Robinson, J. L., Yanofsky, S. D., Jacobs, J. W., Barrett, R. W., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30517 · Cited by 86
Gilbert, H. J., Lowe, C. R., & Drabble, W. T. (1979) · Biochemical Journal · doi:10.1042/bj1830481 · Cited by 84
Jhee, K.-H., McPhie, P., & Miles, E. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000056200 · Cited by 73
Functional characterization of recombinant human ClC‐4 chloride channels in cultured mammalian cells
Vanoye, C. G., & George, A. L. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013115 · Cited by 64
Oliveriusová, J., Kéry, V., Maclean, K., & Kraus, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207087200 · Cited by 62
Maclean, K. N., Jánošík, M., Oliveriusová, J., Kéry, V., & Kraus, J. P. (2000) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)00100-8 · Cited by 55
Evande, R., Blom, H. J., Boers, G. H. J., & Banerjee, R. V. (2002) · Biochemistry · doi:10.1021/bi026248d · Cited by 45
Fetler, L., & Vachette, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4681 · Cited by 27
Research works printed but not linked: 4
- Winder, 1996, Am. J. Physiol., 270, E299
- Merrill, 1997, Am. J. Physiol., 273, E1107
- Winder, 1999, Am. J. Physiol., 277, E1
- Hardie, 2000, Methods Mol. Biol., 99, 63
Cited by
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Self-citationKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Self-citationAMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Self-citationSteinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
Self-citation
Metadata
- Authors
- Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., & Hardie, D. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2004-01-15
- Volume
- 113
- Issue
- 2
- Pages
- 274-284
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC311435
- OpenAlex
- W2166714586
- Cited by
- 754
- References
- 56
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 19 · 2023: 16 · 2022: 18 · 2021: 19 · 2020: 19 · 2019: 23 · 2018: 27 · 2017: 37 · 2016: 25 · 2015: 22 · 2014: 33 · 2013: 35 · 2012: 59
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (QLG1-CT-2001-01488)
- European Commission
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- CBS domain, energy sensing, AMPK, cystathionine beta-synthase, S-adenosylmethionine, pathogenic variants, genetic disorders, nucleotide binding site
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Allosteric Site, Animals, Binding Sites, Cloning, Molecular, DNA, Dose-Response Relationship, Drug, Escherichia coli, Glutathione Transferase, Humans, Kinetics, Ligands, Liver, Models, Molecular, Mutation, Plasmids, Protein Binding, Recombinant Fusion Proteins, Recombinant Proteins, Retinitis Pigmentosa, Polymerase Chain Reaction, Protein Structure, Tertiary, DNA, Complementary, Dimerization, Protein Isoforms, Amino Acid Motifs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.